Screener
LENZ Therapeutics, Inc. LENZ Q3 2025 earnings
Reported November 5, 2025 · Before market open
Revenue$12.5MBeat by $9.5M
EPS-$0.59Beat by $0.08
Revenue estimate$3.0M
EPS estimate-$0.67
Next report
Nov 4, 2026 (in 2 months)Revenue estimate$4.5M
EPS estimate-$1.02
Versus estimates
Revenue
Q2 2026$5.5MBeat by $3.1MQ1 2026$1.9MBeat by $142.1KQ4 2025$1.6MMiss by $1.5M
Q3 2025$12.5MBeat by $9.5M
Q2 2025$5.0MBeat by $4.3MDiluted EPS
FAQ
- When did LENZ Therapeutics, Inc. report Q3 2025 earnings?
- LENZ Therapeutics, Inc. (LENZ) reported Q3 2025 earnings on November 5, 2025 before market open.
- What were LENZ Therapeutics, Inc.'s Q3 2025 revenue and EPS?
- LENZ Therapeutics, Inc. reported revenue of $12.5M and eps of $-0.59 for Q3 2025.
- Did LENZ Therapeutics, Inc. beat estimates in Q3 2025?
- Revenue beat the consensus estimate of $3.0M by $9.5M. EPS beat the consensus estimate of $-0.67 by $0.08.
- How did LENZ Therapeutics, Inc.'s Q3 2025 results compare year-over-year?
- Compared to the same quarter a year prior, eps declined 55.3% from $-0.38.
- Where can I find LENZ Therapeutics, Inc.'s Q3 2025 SEC filings?
- You can read the 8-K earnings release (0001815776-25-000069) and the 10-Q periodic report (0001815776-25-000071) directly on SEC EDGAR. The filing index links above go to sec.gov.
